Biolayer Interferometry (BLI) Market
Biolayer Interferometry (BLI) Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biolayer Interferometry (BLI) Market Size and Growth
The Biolayer Interferometry (BLI) market is poised for significant growth, driven by increasing demand for real-time biomolecular interaction analysis in pharmaceutical and biotechnology sectors. The market size was valued at approximately $275 million in 2023, with projections suggesting continued expansion due to technological advancements and rising research funding. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Ichor Life Sciences
◍ Inc
◍ Creative BioMart
◍ GenScript
◍ ROCKLAND
IMMUNOCHEMICALS
◍ INC
◍ BPS Bioscience
◍ Inc
◍ Creative Proteomics
◍ Creative Biostructure
◍ Profacgen
◍ Creative Biolabs
◍ Biocult
◍ KMD Bioscience Co.
◍ Ltd
◍ LP Information
The Biolayer Interferometry (BLI) market features key players like Ichor Life Sciences, Creative BioMart, and GenScript, providing advanced analytical services and products. These companies enhance BLI applications in drug development and diagnostics, driving market growth through innovation. Financials:
- GenScript: $400 million (2022)
- BPS Bioscience: $50 million (2021).
Request Sample Report
Market Segmentation
By Application
By Product
◍ Diagnostics
◍ Biotechnology
◍ Scientific Research ◍ Others
Others ◍ Pharmaceutical Industry
◍ Affinity and Kinetic Analysis
◍ Drug and Antibody Screening
◍ Drug and Antibody Discovery ◍ Protein Quantification
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
